| |
Before randomization
|
After randomization
|
T1
|
T7
|
p*
|
|---|
|
Placebo
|
mPBMC
|
p
+
|
|---|
|
Cognitive function
|
19
|
31
|
23
|
0.09
|
8
|
11
|
0.59
|
|
Motor function
|
3
|
0
|
2
|
0.15
|
0
|
0
|
–
|
|
Cognitive + motor function
|
5
|
14
|
16
|
0.65
|
13
|
14
|
0.83
|
|
No interval change
|
20
|
2
|
6
|
0.13
|
1
|
0
|
0.28
|
-
mPBMC mobilized peripheral blood mononuclear cell; T1 and T7 refer to a group who received mPBMC at 1 and 7 months of study, respectively
-
+
p indicates statistical significances of items between placebo and mPBMC groups
-
*p indicates statistical significances of items between before T1 and T7 groups
